Cancer Institute of New Jersey at Robert Wood Johnson University Hospital is a clinical research site located in New Brunswick, New Jersey, United States 08901.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Cancer Institute of New Jersey at Robert Wood Johnson University Hospital has participated in 9 clinical trials.
Therapeutic areas: Leukemia, Sarcoma, Neuroblastoma.
Sponsors: National Institutes of Health Clinical Center (CC), Children's Oncology Group, Eastern Cooperative Oncology Group.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cancer Institute of New Jersey at Robert Wood Johnson University Hospital has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cancer Institute of New Jersey at Robert Wood Johnson University Hospital has 9 clinical trials on record. Their work covers Leukemia, Sarcoma, Neuroblastoma.
Yes — Cancer Institute of New Jersey at Robert Wood Johnson University Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.